Saraji, Omair .
HRN: 26-54-38 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/17/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
01/17/2025
01/23/2025
IV
480 Mg
Q6H
PCAP D
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes